Cross Country Healthcare gains 6.2% as Aya deal clears FTC compliance hurdle.
ByAinvest
Friday, Sep 5, 2025 7:13 am ET1min read
CCRN--
The certification marks a significant milestone in the acquisition process, which was first announced on December 4, 2024. Initially, the deal was expected to close by September 3, 2025, but the termination date has been automatically extended to December 3, 2025 [2]. This extension allows the FTC additional time to complete its review, which is crucial for transactions of this scale in the healthcare staffing sector [3].
The merger, valued at approximately $615 million, would see Aya Healthcare acquire Cross Country for $18.61 per share in cash. Aya Healthcare, the largest healthcare staffing firm in the US, is expected to benefit from the acquisition of Cross Country, the seventh-largest healthcare staffing firm in the US [2].
The certification of compliance with the FTC's second request signifies progress in the regulatory review process and helps clarify the path to the expected Q4 2025 closing. Investors can expect further updates as the regulatory process continues, with the merger now anticipated to finalize in the fourth quarter of 2025, pending the satisfaction of customary closing conditions, including the remaining regulatory green lights [3].
References:
[1] https://seekingalpha.com/news/4492456-cross-country-health-gains-amid-certifying-compliance-with-ftc-for-avaya-deal
[2] https://www.staffingindustry.com/news/global-daily-news/aya-cross-country-extend-merger-deadline
[3] https://www.panabee.com/news/cross-country-healthcare-merger-update-end-date-shifts-to-december-as-ftc-review-progres
Cross Country Healthcare shares rose 6.2% after the company and Aya agreed to certify compliance with the Federal Trade Commission for their deal. The certification confirms that the companies have met the FTC's requirements for the acquisition, paving the way for the deal to be completed.
Cross Country Healthcare (NASDAQ: CCRN) saw its shares increase by 6.2% following the company's certification of compliance with the Federal Trade Commission (FTC) for its acquisition deal with Aya Healthcare. The certification, disclosed in an 8-K filing on September 1, 2025, indicates that both companies have substantially complied with the FTC's second request, a standard regulatory step in the review process for significant mergers [1].The certification marks a significant milestone in the acquisition process, which was first announced on December 4, 2024. Initially, the deal was expected to close by September 3, 2025, but the termination date has been automatically extended to December 3, 2025 [2]. This extension allows the FTC additional time to complete its review, which is crucial for transactions of this scale in the healthcare staffing sector [3].
The merger, valued at approximately $615 million, would see Aya Healthcare acquire Cross Country for $18.61 per share in cash. Aya Healthcare, the largest healthcare staffing firm in the US, is expected to benefit from the acquisition of Cross Country, the seventh-largest healthcare staffing firm in the US [2].
The certification of compliance with the FTC's second request signifies progress in the regulatory review process and helps clarify the path to the expected Q4 2025 closing. Investors can expect further updates as the regulatory process continues, with the merger now anticipated to finalize in the fourth quarter of 2025, pending the satisfaction of customary closing conditions, including the remaining regulatory green lights [3].
References:
[1] https://seekingalpha.com/news/4492456-cross-country-health-gains-amid-certifying-compliance-with-ftc-for-avaya-deal
[2] https://www.staffingindustry.com/news/global-daily-news/aya-cross-country-extend-merger-deadline
[3] https://www.panabee.com/news/cross-country-healthcare-merger-update-end-date-shifts-to-december-as-ftc-review-progres

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet